Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01326286 · ClinicalTrials.gov registry record
Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 3,265
- Enrollment target
NCT01326286: Completed study, sponsored by Vanderbilt University.
NCT01326286 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 3,265 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01326286 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 3,265 participants
- Enrollment target
Study Summary
This study will primarily compare the effectiveness of surgery and radiation for localized prostate cancer, the most common male cancer. It will focus on modern technologies and control for differences in patients and treatments that may affect both cancer-related and patient-reported outcomes (such as impotence and incontinence). By figuring out what treatments "work best, in which patients and in whose hands", it will help men with prostate cancer make better decisions regarding their care.
Primary Outcome
Sexual, urinary, bowel and hormonal function and bother subscores will be assessed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,265 participants |
| Start Date | 2011-03 |
| Est. Completion | 2018-09 |
What the finished NCT01326286 record still lists
NCT01326286 is an observational study that tracks outcomes without assigning an intervention. Its 3,265 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01326286 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01326286 about?
NCT01326286 is a clinical study titled "Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer". This study will primarily compare the effectiveness of surgery and radiation for localized prostate cancer, the most common male cancer. It will focus on modern technologies and control for differences in patients and treatments that may affect both cancer-related and patient-reported outcomes (such...
What is the current status of trial NCT01326286?
This trial is currently completed. The enrollment target is 3,265 participants. The study started on 2011-03. Estimated completion is 2018-09.
Who is sponsoring clinical trial NCT01326286?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04077762 · 3,266 participants · NA
Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)
- NCT06953375 · 3,250 participants · NA
Implementation of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty
- NCT06543446 · 3,290 participants · NA
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy
- NCT06815536 · 3,291 participants
Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia